Update on discussions with IDS

RNS Number : 2449V

Omega Diagnostics Group PLC

27 January 2017

 

Omega Diagnostics Group PLC

("Omega" or the "Company")

Update on discussions with Immunodiagnostic Systems Holdings plc

Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces the following update on its discussions with Immunodiagnostic Systems Holdings plc ("IDS").

Further to the interims results announcement in November 2016, IDS has confirmed that its preferred course of action is to pursue an enlarged distribution relationship with the Company. Currently, IDS has contractual rights to be appointed as the Company's exclusive distributor in territories comprising the UK, France, Germany, Austria, Switzerland, Nordic countries and the United States of America. The ongoing discussions will therefore focus on how Omega can attain a more global reach for its Allersys® range of allergy tests in a structure that benefits both organisations. 

Currently, the Company has 41 CE-Marked allergy tests which can be run on the IDS iSYS automated instrument. The Company will provide a further update in due course.

Contacts:

Omega Diagnostics Group PLC	Tel: [phone]
Andrew Shepherd, Chief Executive	www.omegadiagnostics.com
Kieron Harbinson, Group Finance Director
Jag Grewal, Group Sales and Marketing Director
finnCap Ltd	Tel: [phone]
Geoff Nash/James Thompson (Corporate Finance)
Mia Gardner (Corporate Broking)
Walbrook PR Limited	Tel: [phone] or [e-mail]
Paul McManus	Mob: [phone]
Lianne Cawthorne	Mob: [phone]

 

END

 

 

UPDBFMATMBTTBLR